HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2025)

HUTCHMED (China)'s (HCM) quarterly Non-Current Assets came in at $66.1 million in Q4 2025, down 2.15% year-on-year from $67.6 million in Q4 2024, and down 63.99% on a QoQ basis from $183.6 million in Q2 2025.

HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2025) Analysis & Trends

HUTCHMED (China) (HCM) has 11 years of Non-Current Assets data on file, last reported at $66.1 million in Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 2.15% year-over-year to $66.1 million in Q4 2025; TTM through Dec 2025 was $66.1 million, a 2.15% decrease from a year earlier, with the FY2025 full-year figure at $66.1 million, down 2.15% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $66.1 million, down from $183.6 million in the prior quarter.
  • Over the last five years, Non-Current Assets for HCM reached as high as $212.6 million in Q2 2024 and fell as low as $66.1 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $139.4 million across 5 years, with a median of $172.1 million in 2022.
  • Across the five-year window, Non-Current Assets surged 98.75% in 2021 and fell 13.64% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $91.6 million in 2021, then slipped by 12.6% to $80.1 million in 2022, then retreated by 7.65% to $73.9 million in 2023, then declined by 8.63% to $67.6 million in 2024, then fell by 2.15% to $66.1 million in 2025.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $66.1 million in Q4 2025, $183.6 million in Q2 2025, and $67.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - 66.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 66.11 Mn
Jun 30, 2025 183.61 Mn
Dec 31, 2024 67.56 Mn
Jun 30, 2024 212.61 Mn
Dec 31, 2023 73.94 Mn
Jun 30, 2023 207.01 Mn
Dec 31, 2022 80.06 Mn
Jun 30, 2022 172.10 Mn
Dec 31, 2021 91.61 Mn
Jun 30, 2021 181.72 Mn
Mar 31, 2021 196.89 Mn
Dec 31, 2020 93.36 Mn
Jun 30, 2020 91.43 Mn
Dec 31, 2019 95.10 Mn
Sep 30, 2019 177.01 Mn
Jun 30, 2019 185.72 Mn
Mar 31, 2019 189.30 Mn
Dec 31, 2018 161.58 Mn
Jun 30, 2018 183.27 Mn
Dec 31, 2017 107.23 Mn